Feedback / Questions
MEDI1341 - AstraZeneca, Takeda
MEDI1341: Data from P1 trial (NCT04449484) for Parkinson's disease in Q4 2022
(AstraZeneca)
-
Nov 10, 2022 -
Q3 2022 Results
P1 data
•
CNS Disorders • Parkinson's Disease
https://www.astrazeneca.com/content/dam/az/PDF/2022/Q3/Year-to-date_and_Q3_2022_results_clinical_trials_appendix.pdf
Nov 10, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious